Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
About this item
Full title
Author / Creator
Licciardi, Paul , Ververis , Hiong and Karagiannis
Publisher
New Zealand: Taylor & Francis Ltd
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Taylor & Francis Ltd
Subjects
More information
Scope and Contents
Contents
Discusses the use of Histone deacetylase (HDAC) inhibitors as multitargeted therapies for malignancy. Outlines the pharmacology and mechanisms of action of HDAC inhibitors while covering the safety and efficacy of these compounds in clinical studies to date. Describes current HDAC inhibitors in clinical trials : Vorinostat, Depsipeptide, Entinostat...
Alternative Titles
Full title
Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_59ef244e4cd64ca2bf96ff421a175c18
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_59ef244e4cd64ca2bf96ff421a175c18
Other Identifiers
ISSN
1177-5475,1177-5491
E-ISSN
1177-5475,1177-5491
DOI
10.2147/BTT.S29965
